These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63. Ubiquilin-2 (UBQLN2) binds with high affinity to the C-terminal region of TDP-43 and modulates TDP-43 levels in H4 cells: characterization of inhibition by nucleic acids and 4-aminoquinolines. Cassel JA; Reitz AB Biochim Biophys Acta; 2013 Jun; 1834(6):964-71. PubMed ID: 23541532 [TBL] [Abstract][Full Text] [Related]
64. A single mutation at lysine 241 alters expression and trafficking of the D2 dopamine receptor. Kim OJ J Recept Signal Transduct Res; 2008; 28(5):453-64. PubMed ID: 18946766 [TBL] [Abstract][Full Text] [Related]
65. Proteasome-Rich PaCS as an Oncofetal UPS Structure Handling Cytosolic Polyubiquitinated Proteins. In Vivo Occurrence, in Vitro Induction, and Biological Role. Solcia E; Necchi V; Sommi P; Ricci V Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30223470 [TBL] [Abstract][Full Text] [Related]
66. IκB kinase thwarts aggregation: Phosphorylating TDP-43 for degradation. Yang C; Liu Y; Hu F J Cell Biol; 2024 Feb; 223(2):. PubMed ID: 38252412 [TBL] [Abstract][Full Text] [Related]
67. HEXA-018, a Novel Inducer of Autophagy, Rescues TDP-43 Toxicity in Neuronal Cells. Lee S; Jo M; Lee HE; Jeon YM; Kim S; Kwon Y; Woo J; Han S; Mun JY; Kim HJ Front Pharmacol; 2021; 12():747975. PubMed ID: 34925009 [TBL] [Abstract][Full Text] [Related]
68. Managing Hyperosmotic Stress through Phase Separation. Peran I; Sabri N; Mittag T Trends Biochem Sci; 2020 Sep; 45(9):721-723. PubMed ID: 32446814 [TBL] [Abstract][Full Text] [Related]
70. Degradation of TDP-43 and its pathogenic form by autophagy and the ubiquitin-proteasome system. Wang X; Fan H; Ying Z; Li B; Wang H; Wang G Neurosci Lett; 2010 Jan; 469(1):112-6. PubMed ID: 19944744 [TBL] [Abstract][Full Text] [Related]
71. TDP-43 Proteinopathy and ALS: Insights into Disease Mechanisms and Therapeutic Targets. Scotter EL; Chen HJ; Shaw CE Neurotherapeutics; 2015 Apr; 12(2):352-63. PubMed ID: 25652699 [TBL] [Abstract][Full Text] [Related]
73. p62 positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72-linked FTLD and MND/ALS. Al-Sarraj S; King A; Troakes C; Smith B; Maekawa S; Bodi I; Rogelj B; Al-Chalabi A; Hortobágyi T; Shaw CE Acta Neuropathol; 2011 Dec; 122(6):691-702. PubMed ID: 22101323 [TBL] [Abstract][Full Text] [Related]
74. Differential roles of the ubiquitin proteasome system and autophagy in the clearance of soluble and aggregated TDP-43 species. Scotter EL; Vance C; Nishimura AL; Lee YB; Chen HJ; Urwin H; Sardone V; Mitchell JC; Rogelj B; Rubinsztein DC; Shaw CE J Cell Sci; 2014 Mar; 127(Pt 6):1263-78. PubMed ID: 24424030 [TBL] [Abstract][Full Text] [Related]
75. Endogenous TDP-43 localized to stress granules can subsequently form protein aggregates. Parker SJ; Meyerowitz J; James JL; Liddell JR; Crouch PJ; Kanninen KM; White AR Neurochem Int; 2012 Mar; 60(4):415-24. PubMed ID: 22306778 [TBL] [Abstract][Full Text] [Related]
76. Poly-A binding protein-1 localization to a subset of TDP-43 inclusions in amyotrophic lateral sclerosis occurs more frequently in patients harboring an expansion in C9orf72. McGurk L; Lee VM; Trojanowksi JQ; Van Deerlin VM; Lee EB; Bonini NM J Neuropathol Exp Neurol; 2014 Sep; 73(9):837-45. PubMed ID: 25111021 [TBL] [Abstract][Full Text] [Related]
77. Significance and limitation of the pathological classification of TDP-43 proteinopathy. Arai T Neuropathology; 2014 Dec; 34(6):578-88. PubMed ID: 25196969 [TBL] [Abstract][Full Text] [Related]
78. Binding of TDP-43 to the 3'UTR of its cognate mRNA enhances its solubility. Sun Y; Arslan PE; Won A; Yip CM; Chakrabartty A Biochemistry; 2014 Sep; 53(37):5885-94. PubMed ID: 25171271 [TBL] [Abstract][Full Text] [Related]
79. Early retinal neurodegeneration and impaired Ran-mediated nuclear import of TDP-43 in progranulin-deficient FTLD. Ward ME; Taubes A; Chen R; Miller BL; Sephton CF; Gelfand JM; Minami S; Boscardin J; Martens LH; Seeley WW; Yu G; Herz J; Filiano AJ; Arrant AE; Roberson ED; Kraft TW; Farese RV; Green A; Gan L J Exp Med; 2014 Sep; 211(10):1937-45. PubMed ID: 25155018 [TBL] [Abstract][Full Text] [Related]
80. TDP-43 loss of cellular function through aggregation requires additional structural determinants beyond its C-terminal Q/N prion-like domain. Budini M; Romano V; Quadri Z; Buratti E; Baralle FE Hum Mol Genet; 2015 Jan; 24(1):9-20. PubMed ID: 25122661 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]